Sun Pharmaceutical Industries Inc recalls
17 recall notices naming Sun Pharmaceutical Industries Inc since January 2025, in United States. The most recent was published 14 Oct 2026.
17recalls on record
Latest recalls (17)
- FDASUN PHARMACEUTICAL INDUSTRIES INC recalls Tretinoin Cream USP and 1 moreFDAFailed Impurities/Degradation Specifications
- FDASUN PHARMACEUTICAL INDUSTRIES INC recalls Carbamazepine TabletsFDACGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
- FDASUN PHARMACEUTICAL INDUSTRIES INC recalls Fexofenadine Hydrochloride TabletsFDAFailed Impurities/Degradation Specifications
- FDASUN PHARMACEUTICAL INDUSTRIES INC recalls Perampanel CIII TabletsFDALabeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.
- FDASUN PHARMACEUTICAL INDUSTRIES INC recalls DOXOrubin Hydrochloride Liposome injectionFDAPresence of Particulate matter: Particulate matter identified as glass.
- FDASUN PHARMACEUTICAL INDUSTRIES INC recalls Budesonide Inhalation SuspensionFDAPresence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles…
- FDASUN PHARMACEUTICAL INDUSTRIES INC recalls Xyvona (levorphanol tartrate tablets)FDALabeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary…
- FDASUN PHARMACEUTICAL INDUSTRIES INC recalls FluocinonideFDAFailed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
- FDASUN PHARMACEUTICAL INDUSTRIES INC recalls Diclofenac SodiumFDAFailed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
- FDASUN PHARMACEUTICAL INDUSTRIES INC recalls Clindamycin Phosphate USPFDAFailed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
- FDASUN PHARMACEUTICAL INDUSTRIES INC recalls Fluocinolone Acetonide Solution Topical Solution USPFDAFailed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D.
- FDASUN PHARMACEUTICAL INDUSTRIES INC recalls Lisdexamfetamine Dimesylate CapsulesFDAFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability…
- FDASUN PHARMACEUTICAL INDUSTRIES INC recalls Kit for the Preparation of Technetium Tc 99m MertiatideFDAFailed Dissolution Specifications-Out of Specification (OOS) observation for sulphate in Sodium Tartrate Dihydrate used for the production of…
- FDASUN PHARMACEUTICAL INDUSTRIES INC recalls Spironolactone TabletsFDAPresence of foreign substance: identified as aluminum.
- FDASUN PHARMACEUTICAL INDUSTRIES INC recalls Lisdexamfetamine Dimesylate CapsulesFDAFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability…
- FDASUN PHARMACEUTICAL INDUSTRIES INC recalls Gabapentin CapsulesFDACross Contamination
- FDASUN PHARMACEUTICAL INDUSTRIES INC recalls Morphine Sulfate Extended-Release TabletsFDAFailed Dissolution Specifications